Floatz logo

1-((2,6-DIFLUOROPHENYL)SULFONYL)-4-((4-METHOXYPHENYL)SULFONYL)PIPERAZINE

Healthy Subject

Guido A. Davidzon, MD, SMSmall moleculePhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Healthy Subject cohort.

Asset / SponsorPhaseRating
[18F]FP-R01-MG-F2
Stanford University
Early Phase 1CC

Same molecule, other indications

1-((2,6-DIFLUOROPHENYL)SULFONYL)-4-((4-METHOXYPHENYL)SULFONYL)PIPERAZINE is also rated in:

brain neoplasmDormant
CC
Indicative ·
43 / 100
View asset →
glioblastomaDormant
C
Indicative ·
37 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →